ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 53 filers reported holding ALIGOS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $69,223 | +11.1% | 71,290 | 0.0% | 0.00% | – |
| Q1 2023 | $62,307 | -8.3% | 71,290 | 0.0% | 0.00% | – |
| Q4 2022 | $67,939 | -12.9% | 71,290 | 0.0% | 0.00% | – |
| Q3 2022 | $78,000 | -9.3% | 71,290 | 0.0% | 0.00% | – |
| Q2 2022 | $86,000 | -52.0% | 71,290 | -14.1% | 0.00% | – |
| Q1 2022 | $179,000 | -82.1% | 83,039 | -1.6% | 0.00% | – |
| Q4 2021 | $1,001,000 | -22.9% | 84,397 | +0.8% | 0.00% | -100.0% |
| Q3 2021 | $1,299,000 | -33.9% | 83,752 | -13.2% | 0.00% | 0.0% |
| Q2 2021 | $1,966,000 | -4.5% | 96,491 | +6.6% | 0.00% | 0.0% |
| Q1 2021 | $2,059,000 | +950.5% | 90,510 | +1177.8% | 0.00% | – |
| Q4 2020 | $196,000 | – | 7,083 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,320,381 | $2,808,000 | 4.30% |
| Pivotal bioVenture Partners Investment Advisor LLC | 743,215 | $899,000 | 0.45% |
| Vivo Capital, LLC | 3,547,030 | $4,292,000 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 1,547,710 | $1,873,000 | 0.28% |
| Newtyn Management, LLC | 962,088 | $1,164,000 | 0.22% |
| EcoR1 Capital, LLC | 3,948,360 | $4,778,000 | 0.16% |
| Boxer Capital, LLC | 1,526,048 | $1,847,000 | 0.12% |
| Novo Holdings A/S | 1,950,000 | $2,360,000 | 0.12% |
| HHLR ADVISORS, LTD. | 2,365,064 | $2,862,000 | 0.06% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 58,392 | $71,000 | 0.02% |